Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - Net
Ratios

Insight Molecular Diagnostics (IMDX) Depreciation & Amortization (IS) (2024 - 2025)

Insight Molecular Diagnostics (IMDX) has disclosed Depreciation & Amortization (IS) for 2 consecutive years, with $563000.0 as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (IS) changed 0.0% to $563000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.2 million through Dec 2025, up 40.47% year-over-year, with the annual reading at $2.2 million for FY2025, 40.47% up from the prior year.
  • Depreciation & Amortization (IS) hit $563000.0 in Q4 2025 for Insight Molecular Diagnostics, down from $584000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (IS) ranged from a high of $584000.0 in Q3 2025 to a low of $326000.0 in Q2 2024.